Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Manteia_Predictive_Medicine> ?p ?o }
Showing triples 1 to 33 of
33
with 100 triples per page.
- Manteia_Predictive_Medicine abstract "\"Manteia Predictive Medicine S.A.\" (initially incorporated under the name \"GenInEx S.A.\") was a start-up company created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, and private founders. Its aim was to provide preventive and curative treatment guidelines for common and complex diseases. These guidelines were envisaged as composed of two parts: a \"personal genome card\" containing the entire genome sequence of the person holding the card, an Internet link to a treatment database to be interrogated at the doctor's practice.The company was basing its strategy on the development of the so-called \"DNA colony sequencing\" technology (now commercialized by Illumina), its proprietary massive parallel sequencing technology whose development had been initiated in late 1996 at Glaxo-Welcome's Geneva Biomedical Research Institute (GBRI), by Dr Pascal Mayer and Dr Laurent Farinelli. This work has been protected by several patents and patents applications, publications and invited oral communications at international conferences from 1998 to 2001.By the end of 2003, while the company was progressing along its plans towards realizing an industrial instrument capable of sequencing a complete human genome in approximatively 24h, strategic considerations led the main shareholder (Serono) to sell Manteia's colony DNA sequencing technology to UK based \"Solexa Ltd\", now part of Illumina (company),.".
- Manteia_Predictive_Medicine wikiPageExternalLink 6b6.
- Manteia_Predictive_Medicine wikiPageID "31722201".
- Manteia_Predictive_Medicine wikiPageLength "4600".
- Manteia_Predictive_Medicine wikiPageOutDegree "12".
- Manteia_Predictive_Medicine wikiPageRevisionID "690106019".
- Manteia_Predictive_Medicine wikiPageWikiLink Category:Biotechnology_companies.
- Manteia_Predictive_Medicine wikiPageWikiLink Category:Biotechnology_companies_of_Switzerland.
- Manteia_Predictive_Medicine wikiPageWikiLink Category:Companies_established_in_2000.
- Manteia_Predictive_Medicine wikiPageWikiLink Category:DNA_sequencing.
- Manteia_Predictive_Medicine wikiPageWikiLink Genome.
- Manteia_Predictive_Medicine wikiPageWikiLink Illumina_(company).
- Manteia_Predictive_Medicine wikiPageWikiLink Illumina_dye_sequencing.
- Manteia_Predictive_Medicine wikiPageWikiLink Massive_parallel_sequencing.
- Manteia_Predictive_Medicine wikiPageWikiLink Sequencing.
- Manteia_Predictive_Medicine wikiPageWikiLink Serono.
- Manteia_Predictive_Medicine wikiPageWikiLinkText "Manteia Predictive Medicine".
- Manteia_Predictive_Medicine wikiPageUsesTemplate Template:Reflist.
- Manteia_Predictive_Medicine subject Category:Biotechnology_companies.
- Manteia_Predictive_Medicine subject Category:Biotechnology_companies_of_Switzerland.
- Manteia_Predictive_Medicine subject Category:Companies_established_in_2000.
- Manteia_Predictive_Medicine subject Category:DNA_sequencing.
- Manteia_Predictive_Medicine hypernym Company.
- Manteia_Predictive_Medicine type Company.
- Manteia_Predictive_Medicine type Company.
- Manteia_Predictive_Medicine type Establishment.
- Manteia_Predictive_Medicine comment "\"Manteia Predictive Medicine S.A.\" (initially incorporated under the name \"GenInEx S.A.\") was a start-up company created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, and private founders. Its aim was to provide preventive and curative treatment guidelines for common and complex diseases.".
- Manteia_Predictive_Medicine label "Manteia Predictive Medicine".
- Manteia_Predictive_Medicine sameAs Q6752017.
- Manteia_Predictive_Medicine sameAs m.0gmh4p6.
- Manteia_Predictive_Medicine sameAs Q6752017.
- Manteia_Predictive_Medicine wasDerivedFrom Manteia_Predictive_Medicine?oldid=690106019.
- Manteia_Predictive_Medicine isPrimaryTopicOf Manteia_Predictive_Medicine.